Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Globalization Bill Should Link IT Systems Across Import Safety – Stakeholders

This article was originally published in The Tan Sheet

Executive Summary

Draft legislation to reform FDA's import safety oversight fails to address the agency's urgent need to improve the IT connections between its own divisions as well as with other agencies, drug industry stakeholders say

You may also be interested in...



Globalization Act’s Drug Safety Provisions Look Harmful For Industry

The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys

Globalization Act’s Drug Safety Provisions Look Harmful For Industry

The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys

Globalization Act’s Drug Safety Provisions Look Harmful For Industry

The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys

Related Content

Topics

UsernamePublicRestriction

Register

PS101640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel